Relationship: annual-meeting

2024 Annual Meeting Agenda

Thursday, April 11, 2024
10:00-11:00 AM	Registration & Coffee
11:00-11:05 AM	Welcome & Introductions
11:03- 2:20 PM	Session 1
12:05-12:35 PM	Coffee Break
1:20- 2:20 PM	Lunch
2:20-2:25 PM	Session 2
2:55- 3:20 PM	Coffee Break and Exhibits
4:20 PM	Adjourn
4:20-6:00 PM	Social Activity: Welcome Reception
Friday, April 12, 2024
7:00-8:00 AM	Registration & Breakfast
8:00-8:05 AM	Session 3
8:55-9:15 AM	Panel Discussion
9:15-9:45 AM	Coffee Break & Exhibits
10:35-10:55 AM	Panel Discussion
10:55-11:55 PM	Presidential Address
12:00-1:00 PM	Lunch and Learn
1:00 PM	Adjourn
1:30-5:45 PM	Social Activity: FVS/FVF Golf Tournament
Saturday, April 13, 2024
7:00-8:00	Registration & Breakfast
8:00-8:05	Session 4
9:50-10:20 AM	Coffee Break, Poster Hall & Exhibits
10:20- 12:15 PM	Session 5
1:05-2:05 PM	Annual Business Meeting
2:05 PM	Adjourn
3:00-5:30 PM	Social Activity: Splash Bash
Sunday, April 14, 2024
7:00-8:00 AM	Registration, Poster Hall and Breakfast
8:00-8:05 AM	Session 6
9:05-9:25 AM	VP Panel Discussion
9:25-9:55 AM	Coffee Break
9:55- 10:05 AM	Award Ceremony
10:05- 10:15 AM	Session 7
11:45 AM	Adjourn

2024 Florida Vascular Visiting Professors

---

 

Anahita Dua, MD

Dr. Dua is a vascular surgeon at Massachusetts General Hospital and an Associate Professor of Surgery at Harvard Medical School. At Mass General, she is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, associate director of the Vascular Surgery Clerkship and director of clinical research for the division of vascular surgery. She specializes in advanced endovascular (minimally invasive) and traditional (open) limb salvage techniques for treating peripheral arterial disease and critical limb ischemia, diabetic limb disease, aortic disease, carotid disease, thoracic outlet syndrome and venous disease.

Dr. Dua completed her vascular surgery fellowship at Stanford University Hospital, her general surgery residency at the Medical College of Wisconsin and her medical school in the United Kingdom at the University of Aberdeen. She has also completed a master’s degree in trauma sciences, a master’s in business administration in health care management and has a certificate in health economics and outcomes research as well as a certificate in drug and device development from the Massachusetts Institute of Technology. She is board-certified in vascular surgery, general surgery and advanced wound care and management.

Dr. Dua has published over 150 peer reviewed papers and has edited five vascular surgery medical textbooks. She serves on multiple national vascular surgery committees through the Society for Vascular Surgery and other vascular organizations including the South Asian-American Vascular Society and American College of Surgeons. She is the president of the South Asian American Vascular Surgery Society.

Dr. Dua’s lab NIH-funded lab focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization. She is interested in creation precision, point of care medical approaches to anticoagulation for patients post revascularization. Her clinical and outcomes research focuses primarily on diseases involving peripheral vascular disease, limb salvage and critical limb ischemia. She is part of a technology development team that creates tools to increase walking distance and wound healing while decreasing pain in patients with peripheral vascular disease. Dr. Dua is also involved heavily in surgical outcomes-based research using large medical databases to generate both quality outcomes and cost effectiveness data.

Dr. Dua is a self-described animal lover and rescuer of pitbulls. At one point, she housed 14 pitbull puppies and their mother at once. Nowadays, her spare time is spent with her husband, son, daughter and dog Leo.

---

 

Jason T. Lee, MD

Dr. Lee is the chief of vascular surgery for Stanford Medicine. He is a fellowship-trained, board-certified vascular surgeon and a world-renowned leader in the field.

He has a strong “patient first” philosophy of care. For every case, he emphasizes the most advanced, minimally invasive diagnostic and treatment approaches. He works closely with a multidisciplinary team of specialists to ensure that each care plan is personalized, precise, compassionate, and comprehensive.

Dr. Lee also is passionate about educating and mentoring tomorrow’s vascular surgeons. He is a professor of surgery at Stanford University School of Medicine. He serves as past president of the Vascular and Endovascular Surgery Society and is current president of the Association of Program Directors in Vascular Surgery.

Other leadership roles have been in the Society for Vascular Surgery, the Society for Clinical Vascular Surgery, National Comprehensive Cancer Network, American Heart Association, and American Board of Surgery.

Dr. Lee champions clinical and translational research. His research findings have helped advance minimally invasive endovascular aneurysm repair (EVAR) and other surgical procedures.
He has made nearly 600 presentations worldwide, including 200 peer-reviewed abstract presentations at meetings of the Society for Vascular Surgery, American Association for Thoracic Surgery, and other conferences.

He has co-authored dozens of book chapters and published more than 200 articles on innovations in the treatment of aortic aneurysms, vascular trauma, deep vein thrombosis, and athletic vascular disorders. His work has appeared in the Journal of Vascular Surgery, Annals of Surgery, JAMA Surgery, and other peer-reviewed journals.

Dr. Lee has earned extensive recognition for his achievements. The Vascular and Endovascular Surgery Society, Society for Vascular Surgery, National Institutes of Health, Robert Wood Johnson Foundation, and many other organizations have honored his work.

He is a member of the American Surgical Association, Society for Vascular Surgery, International Society of Endovascular Specialists, and other professional societies.

---

 

David A. Rigberg, MD

Dr. Rigberg is an Associate Professor of Surgery in the Division of Vascular Surgery at the David Geffen School of Medicine at UCLA. He earned his bachelor’s degree at the University of Pennsylvania and his medical degree at the University of Arizona in Tucson. He completed his internship and residency in general surgery at UCLA, and then was the vascular fellow at UCLA as well. This training included open vascular surgery as well as catheter-based endovascular interventions.

Dr. Rigberg has published extensively in the basic and clinical sciences, including work in the field of outcomes from aortic operations.

He has also written on a variety of topics, including Takayasu’s arteritis and Thoracic Outlet Syndrome. Other research interests include the development of new devices for vascular procedures using thin-film Nitinol, work for which he recently received a one million dollar NIH Grant.
Dr. Rigberg is a full-time faculty member at UCLA, and is also the section chief of vascular surgery at Santa Monica-UCLA Hospital, with a practice encompassing all aspects of open and endovascular interventions.

In addition, he has an appointment at the Veterans’ Administration Hospital.

Abstracts

---

All current surgery residents or vascular fellows in the state of Florida are encouraged to submit an abstract for oral presentation. Abstract submission carries with it the eligibility to receive the Jose “Pepe” Alvarez, Jr., MD Resident Award, the Dr. JJ Karmacharya Award or the Mark L. Friedell, MD Award.

About the Awards

Jose “Pepe” Alvarez, Jr., MD Resident Award: Awarded for the best overall abstract and oral presentation for clinical or experimental work performed by residents of fellows in training. Awardee receives $1,000 and will be considered for publication in the Annals of Vascular Surgery. This award is sponsored by the Florida Vascular Foundation.

Dr. JJ Karmacharya Award: Awarded for the best abstract and oral presentation in aortic aneurysmal disease reconstruction and treatments. Awardee receives $1,000. This award is sponsored by the JJ Karmacharya Foundation for Vascular Surgery.

Mark L. Friedell, MD Award: Awarded for the Best Medical Student Abstract and Oral Presentation. Awardee receives $500.00.

*You may be eligible for both the Resident Award and the FVF Scholarship.

Annals of Vascular surgery:
The official journal of the Florida Vascular Society is the Annals of Vascular Surgery. Acceptance of an abstract for oral presentation at the FVS Annual Scientific Sessions carries with it the following options:

1. To be printed in an edition of the Annals of Vascular Surgery featuring the Florida Vascular Society Annual Scientific Sessions; and
2. The author may submit a Manuscript to the Annals of Vascular Surgery to be considered for

When submitting your abstract form online, please remember to email your current Curriculum Vitae to abstracts@fvs.org.

Abstract Submission Timeline

---

Abstract Site Opens for Submission
Window Opens: September 4th, 2023.

Deadline for Abstract Submission:
Window Closes: October 16th, 2023.

Submission Rules and Guidelines

---

Rules for Submission:
Abstracts submitted to the Florida Vascular Society for consideration for the Annual Meeting program must be original work and must not have been published or presented at a national or regional meeting. It is acceptable to submit work that has been presented at local meetings or as a poster, provided it has not been published.

No reference should be made on or in the abstract to the names or institutions of the authors, as the abstract review process is conducted “blindly”, in that the reviewers do not know the origin of the work. Non-member authors must list the name of a member sponsor.

Abstract Format:
Abstracts must be submitted as a structured format (Introduction/Objectives, Methods, Results, and Conclusion) using the Abstracts Submission and Transmittal Forms. A current CV must be submitted with your submission.

Topics:
All vascular related topics submitted will be considered by the FVS program committee for acceptance throughout the program. Topics related to the following areas will be given the highest consideration for acceptance in the James E. Seeger, MD Symposium, Luncheon Session, and Topic Related Scientific Sessions:

• Vascular Medicine
• Lower Extremity Revascularization
• Vascular Trauma
• Carotid Dissection Aneurysms
• Dialysis Access

Start Online Abstract Submission

Exhibits & Support

---

 

Join us on April 11-14, 2024 at the FVS’s 37th Annual Scientific Sessions!  Exhibitors will connect with 100-150 vascular surgeons during the conference with over 11 hours of face-to-face time during networking functions.

 

Register to Exhibit

Download Prospectus

Venue

---

 

Waldorf Astoria Orlando 
14200 Bonnet Creek Resort Lane
Orlando, FL 32821

The Florida Vascular Society looks forward to welcoming you to Orlando for the 37th Annual Scientific Sessions, April 11-14, 2024. 

       

FVS Discounted Rate: $309/night + tax and $25 resort fee.

Reservation Cut-off: Monday, March 11, 2024 (or until the room block is filled, whichever comes first).

Reservations: Call 407-597-5500 and ask for the FVS room rate or:

Virtual Exhibit Hall

---

www.acutewoundcare.com

 

www.silkroadmed.com

 

 

 

Accreditation

---

Coming Soon

Agenda

Download Agenda File

---

*Agenda is subject to change

Friday, April 23, 2021

Product Theater (11:45 AM-12:45 PM)

11:45 AM-12:45 PM:  Product Theater: A Review on the New Treo Abdominal Stent-graft: From Features to Clinical Practice by Javairiah Fatima, MD, sponsored by Terumo.

Welcome and Overview 

1:00-1:05 PM: Welcome & Introductions by Charles Thompson, MD, President

Session I: The Next Generation

Case Series & Panel Discussion (1:05-2:35 PM)

Moderator: Charles Thompson, MD

1:05-1:20 PM: Femoral Flow Redirection (FRED) Technique to Limit Visceral Artery Ischemia During Fenestrated Endovascular Aortic Repair (FEVAR) by Ahmed Ghamraoui, DO

1:20-1:35 PM: Percutaneous Endovascular Abdominal Aortic Aneurysm Repair with Monitored Anesthesia Care Decreases Operative Time but Not Pulmonary Complications by Joshua Kronenfeld, MD

1:35-1:50 PM: Endovascular and Open Surgical Treatment of Peripheral Artery Disease in Patients with HIV by Lauren Harry, MD

1:50-2:05 PM: Traumatic Lower Extremity Vascular Injuries and Limb Salvage in a Civilian Urban Trauma Center by Eva Urrechaga, MD

2:05-2:20 PM: Proximal Fixation of Endovascular Aortic Device Does Not Play A Role In Renal Function Decline After Abdominal Aortic Aneurysm Repair by Camila Franco Mesa, MD

2:20-2:35 PM: Panel Discussion

Case Reports & Panel Discussion (2:35-4:00 PM)

Moderator: Murray Shames, MD

2:35-2:45 PM: Vascular Thoracic Outlet Syndrome in 2 Pediatric Patients by Rachel Pruett, MD

2:45-2:55 PM: The Migrating Bullet: A Case Report of a Venous Bullet Embolism by Leslie Meredith, MD

2:55-3:05 PM: Delayed Presentation of a Traumatic Radial Artery Pseudoaneurysm by Megan Cibulas, MD

3:05-3:15 PM: Total Autogenous Revascularization of an Innominate Artery Occlusive Disease by Ulegbek Negmadjanov, MD

3:15-3:25 PM: Surgical Repair of Complex, Distal Internal and Common Carotid Artery Aneurysm by Thomas Dougherty, MD

3:25-3:35 PM: Coil Embolization of a Massive Renal Artery Pseudoaneurysm Following Trauma: A Case Report by Alireza Daneshpajouh, DO

3:35-3:50 PM: Panel Discussion

Basic Science Reports & Panel Discussion (4:00-4:45 PM)

Moderator: Murray Shames, MD

4:00-4:15 PM: Pro-Angiogenic Cascade Signaling as the Mechanism for Vascular Regenerative Medicine by Hallie Quiroz, MD

4:15-4:30 PM: Exploring Further Utilization of Biomechanical Characterization of the Vascular System via Ultrasonography by Matthew Jorgensen

4:30-4:45 PM: Panel Discussion

Product Theater (4:45-5:45 PM)

4:45-5:45 PM:  Product Theater: Early Experience with the FDA Approved GORE^® EXCLUDER^® Conformable AAA Endoprosthesis with ACTIVE CONTROL System by Erin Moore, MD. Use of Covered Balloon Expandable Stents for Treatment of Complex AIOD: 3 Year Data and Insights from the Gore VBX Flex Clinical Study by Jean Panneton, MD, sponsored by Gore.

Saturday, April 24, 2021
8:00-8:05 AM: Welcome & Introductions by Charles Thompson, MD, President

Session II: The Next Generation

Case Series & Panel Discussion (8:05-9:35 PM)

Moderator: Deepak Nair, MD

8:05-8:20 AM: Re-discovering an Old Standard: Ilio-Femoral Bypass with Adjunctive Procedures, for Primary or Secondary Iliac Artery Occlusion by Arthur Palamara, MD

8:20-8:35 AM: Office-Based Tunneled Hemodialysis Catheter Removals: Evaluating Safety, Quality, and Cost by Emilie Giuffre, BS

8:35-8:50 AM: Patient-Specific Treatment for Prosthetic Graft Infections: A Reproducible Protocol Using Antibiotic-Loaded Polymethylmethacrylate Beads by Eduardo Rodriguez Zoppi, MD

8:50-9:05 AM: Below Knee Amputation with Resection of the Gastrocnemius and Soleus Muscles (BG) by Paul Citrin, MD

9:05-9:20 AM: Negative Pressure Wound Therapy for Management of Complex Lymphoceles by Vasiliy Ovakimyan, MD

9:20-9:35 AM: Panel Discussion

Case Reports & Panel Discussion (9:35-11:00 AM)

Moderator: Arash Bornak, MD

9:35-9:45 AM: Case Report on Deep Vein Arterialization in No Option Peripheral Arterial Disease by Ivana Vasic, MD

9:45-9:55 AM: May-Thurner Syndrome: Case Report of an Unusual Cause of DVT by Karina Cardenas, MD

9:55-10:05 AM: Percutaneous Embolization of a Ruptured Mycotic Visceral Aortic Aneurysm Stump Hemorrhage by Samuel Nussbaum

10:05-10:15 AM: Peripheral Vascular Bypass with Cadaveric Arterial Allograft in a Toddler with Femoral Mycotic Aneurysm by Kirby Quinn

10:15-10:25 AM: A Hybrid Approach in the Management of a Large Pancreaticoduodenal Artery Aneurysm by Ulugbek Negmadjanov, MD

10:25-10:35 AM: External Iliac Artery Pseudoaneurysm secondary to Perforated Sigmoid Diverticulitis by Joseph Halinski, MD

10:35-10:45 AM: Pediatric Popliteal Artery Pseudo-Aneurysm: A Case Report and Literature Review by Estela Abich, MD

10:45-11:00 AM: Panel Discussion

11:00-11:15 AM: Break

Florida Vascular Society Business Meeting

11:15-11:45 AM: Business Meeting – To view the Business Meeting Minutes from 2020 please click here.

Product Theater (11:45 AM – 12:45 PM)

11:45 AM- 12:45 PM: TCAR: The Establishment of a Less Invasive Approach to Stroke Prevention by Peter Schneider, MD and Inkyoung Parrack, MD, sponsored by Silk Road Medical